England is recording nearly 400 antibiotic-resistant infections per week in 2024, according to UK Department of Health and Social Care data, even as NHS prescribing practices remain below pre-pandemic levels. The figures highlight a persistent burden of antimicrobial resistance (AMR) despite improvements in hospital antibiotic stewardship, while private sector prescribing has increased.
Key takeaways
- Nearly 400 antibiotic-resistant infections per week recorded in England during 2024, according to UK health authorities
- NHS antibiotic prescribing remains below 2019 levels, indicating effective stewardship in the public sector
- Private sector antibiotic prescribing has increased, potentially offsetting public health gains in resistance prevention
Antibiotic prescribing patterns: NHS versus private sector in England
NHS antibiotic use remains below 2019 baseline; private sector shows upward trend, 2024
Source: UK Department of Health and Social Care, 2024 | Georgian Medical Journal News
NHS prescribing below pandemic peak but resistance burden persists
According to UK health authorities, antibiotic prescribing within the National Health Service has successfully remained below 2019 pre-pandemic levels, indicating sustained stewardship efforts. However, the persistence of nearly 400 antibiotic-resistant infections per week suggests that prescribing reduction alone is insufficient to control the growing burden of resistant pathogens.
The disconnect between reduced NHS prescribing and continued high infection rates reflects the complexity of antimicrobial resistance. Resistance emerges not only from contemporary prescribing but also from historical overuse, patient adherence to incomplete courses, and transmission in healthcare and community settings. This data appears in the context of broader global health efforts to combat antimicrobial resistance through the lens of sustainable prescribing practices.
Private sector antibiotic prescribing increases despite public health warnings
While NHS prescribing has declined, the UK Department of Health and Social Care reports that private sector antibiotic prescribing has risen in 2024. This trend is concerning because privately prescribed antibiotics often fall outside formal stewardship monitoring and surveillance systems, potentially contributing to resistance development without visibility to public health authorities.
The divergence between public and private prescribing patterns raises questions about the effectiveness of targeted stewardship campaigns when a significant proportion of prescriptions bypass coordinated oversight. This phenomenon reflects broader quality and safety challenges in fragmented healthcare systems where private providers operate under different regulatory frameworks than public hospitals.
Nearly 400 antibiotic-resistant infections are recorded per week in England despite NHS prescribing reductions, highlighting the persistence of resistance even when stewardship improves in the public sector.
— UK Department of Health and Social Care, 2024
Implications for resistance surveillance and future stewardship
The 2024 data underscore a critical lesson: prescribing reduction in hospitals must be paired with coordinated surveillance across all sectors and continued infection prevention efforts. Clinical practice guidelines increasingly emphasise the need for integrated antibiotic stewardship programmes that extend beyond hospitals into primary care and private practice.
The sustained burden of resistant infections also reflects the time lag between prescribing changes and their epidemiological impact. Resistance patterns established over decades cannot be reversed by a single year of improved prescribing, meaning continued vigilance and multi-sector coordination will be essential through the coming years.
What this means
Frequently asked questions
Why does NHS prescribing reduction not fully explain the decline in resistant infections?
Antibiotic resistance emerges from years of historical overuse and persists in the environment and human microbiota long after prescribing changes. Additionally, resistance spreads person-to-person, meaning infections seen in 2024 may reflect prescribing patterns from previous years. The ~400 weekly infections therefore reflect a lagged response to improved stewardship.
What is the risk from increased private sector antibiotic prescribing?
Private prescriptions often occur outside formal antibiotic stewardship programmes and surveillance systems, meaning they are not monitored for appropriateness or tracked for resistance patterns. This creates a blind spot in public health oversight and can inadvertently fuel resistance development without detection.
What can patients do to help reduce antibiotic resistance?
Patients should take antibiotics only when prescribed, complete the full course even if symptoms improve, and never request antibiotics for viral infections like colds or flu. Practicing good hygiene, staying up-to-date with vaccinations, and reporting infections promptly to clinicians also help limit resistance spread.
The 2024 antibiotic resistance data underscore that stewardship progress in hospitals, while measurable, must be accompanied by coordinated control across primary care, private practice, and the broader community to substantially reduce the disease burden of resistant infections. Policymakers, clinicians, and the public all have roles in ensuring that prescribing improvements translate into clinically meaningful reductions in resistant infections.
Source: Nearly 400 antibiotic-resistant infections each week in 2024, UK Department of Health and Social Care
Was this article helpful?
Related Coverage
